Decision of

regarding the sole control acquisition of Laboratoires Iprad Santé and Laboratoires Iprad Pharma companies by Biocodex company

Meaning of the decision issued on: December 27, 2019

|

Decision issued on: February 25, 2020

Print the page

Presentation of the decision

Information about the decision

Green light to the takeover of Iprad by Biocodex

Print the page

The Autorité clears the takeover of Iprad by Biocodex

Print the page

Sale of hearing aids: the Autorité de la concurrence clears the acquisition of Audilab by the Demant group, subject to conditions

prothèses auditives
Print the page

Sale of hearing aids: the Autorité de la concurrence clears the acquisition of Audilab by the Demant group, subject to conditions.

Print the page

In-depth examination into Elsan's plans to acquire Hexagone Santé Méditerranée

Cliniques

Elsan notified the Autorité de la concurrence of its plans to take exclusive control of Hexagone Santé Méditerranée (HSM).

Print the page

The Autorité de la concurrence has begun an in-depth (Phase 2) examination into Elsan’s plans to acquire Hexagone Santé Méditerranée

Print the page

The Autorité has fined the companies bioMérieux and Guyane Service Médical for continuing to implement an exclusive import agreement, after the Lurel Act came into force.

Print the page